tiprankstipranks
Aurinia Pharmaceuticals (GB:0UJF)
:0UJF
UK Market

Aurinia Pharmaceuticals (0UJF) Income Statement

Compare
0 Followers

Aurinia Pharmaceuticals Income Statement

Last quarter (Q4 2024), Aurinia Pharmaceuticals's total revenue was $59.87M, an increase of 32.76% from the same quarter last year. In Q4, Aurinia Pharmaceuticals's net income was $1.43M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 235.13M$ 175.51M$ 134.03M$ 45.60M$ 50.12M
Gross Profit
$ 206.88M$ 161.37M$ 128.37M$ 44.51M$ -209.00K
Operating Expenses
$ 211.57M$ 253.06M$ 239.84M$ 225.25M$ 147.60M
Depreciation and Amortization
$ 19.45M$ 11.65M$ 2.71M$ 2.76M$ 1.37M
EBITDA
$ 31.73M$ -63.05M$ -103.65M$ -177.44M$ -102.92M
Operating Income
$ -4.69M$ -91.69M$ -111.47M$ -180.74M$ -104.29M
Other Income/Expenses
$ 12.13M$ 14.22M$ 5.12M$ 529.00K$ 1.52M
Pretax Income
$ 7.45M$ -77.47M$ -106.35M$ -180.21M$ -102.77M
Net Income
$ 5.75M$ -78.02M$ -108.18M$ -180.97M$ -102.68M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.04$ -0.54$ -0.76$ -1.40$ -0.87
Diluted EPS
$ 0.04$ -0.54$ -0.76$ -1.40$ -0.87
Weighted Average Shares Outstanding
143.06M 143.24M 141.91M 129.37M 118.47M
Weighted Average Shares Outstanding (Diluted)
146.19M 143.24M 141.91M 129.37M 118.47M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis